Literature DB >> 29943358

Hypertension and Organ Damage in Women.

Maria Lorenza Muiesan1,2,3, Anna Paini4,5,6, Carlo Aggiusti4,5,6, Fabio Bertacchini4,5,6, Claudia Agabiti Rosei4,5,6, Massimo Salvetti4,5,6.   

Abstract

An adequate cardiovascular (CV) prevention strategy in women should consider the acknowledgement of sex-specific risk factors, such as hypertension in pregnancy, the concomitant presence of autoimmune diseases and the benefit of evaluating subclinical organ damage and treating hypertension. In accordance to current guidelines, the diagnostic approach does not differ between men and women, although the cardiac response to pressure overload may suggest greater sensitivity in women, and may vary according to age, ethnic background and obesity, that potentiates the effect of hypertension on left ventricular (LV) hypertrophy. Several studies have observed peculiar abnormalities in LV systolic and diastolic function according to gender. The possible mechanisms that influence a different cardiac adaptation to chronic pressure overload in men and women are not fully understood, although hormonal status, and in particular the lack of estrogen effects after menopause may contribute to the cardiovascular adaptation response to increased afterload. The increase in LV mass in response to chronic pressure overload is associated with higher LV ejection fraction in women than in men and LV torsion is maintained with aging in women but not in men. Interstitial fibrosis may reduce circumferential shortening and early diastolic strain rate, in the presence of a preserved ejection fraction in women, favoring the development of heart failure with preserved ejection fraction. Changes in aortic stiffness with aging may influence cardiac structural and functional changes. Isolated systolic hypertension reflects an increase in aortic stiffness, is frequent in women and may be associated to a greater development of concentric LVH. The regression of hypertensive LVH is more difficult in women, and residual hypertrophy is more common in women than in men despite effective antihypertensive treatment and blood pressure control. Carotid atherosclerosis has been extensively investigated in men and women, showing that women usually develop carotid plaques after menopause, with smaller and less unstable plaques; however large and/or a hypoechogenic plaques are more strictly related to cerebrovascular events in women than in men. More advanced abnormalities in the subcutaneous microcirculation have been recently observed, and well translate in the evidence of more prevalent coronary microcirculation involvement in women ischemic heart disease. The prevalence of albuminuria and of reduced estimated glomerular filtration rate (eGFR < 60 ml/min/1.73) are respectively lower and higher in postmenopausal women than in men. Experimental data suggest the possible involvement of renin-angiotensin-aldosterone system and of T regulatory lymphocytes to this regard.

Entities:  

Keywords:  Albuminuria; Aortic stiffness; Chronic kidney disease; Left ventricular hypertrophy; Small arteries; Target organ damage; Women

Mesh:

Substances:

Year:  2018        PMID: 29943358     DOI: 10.1007/s40292-018-0265-0

Source DB:  PubMed          Journal:  High Blood Press Cardiovasc Prev        ISSN: 1120-9879


  43 in total

1.  Ambulatory blood pressure monitoring in 9357 subjects from 11 populations highlights missed opportunities for cardiovascular prevention in women.

Authors:  José Boggia; Lutgarde Thijs; Tine W Hansen; Yan Li; Masahiro Kikuya; Kristina Björklund-Bodegård; Tom Richart; Takayoshi Ohkubo; Jørgen Jeppesen; Christian Torp-Pedersen; Eamon Dolan; Tatiana Kuznetsova; Agnieszka Olszanecka; Valérie Tikhonoff; Sofia Malyutina; Edoardo Casiglia; Yuri Nikitin; Lars Lind; Gladys Maestre; Edgardo Sandoya; Kalina Kawecka-Jaszcz; Yutaka Imai; Jiguang Wang; Hans Ibsen; Eoin O'Brien; Jan A Staessen
Journal:  Hypertension       Date:  2011-01-24       Impact factor: 10.190

Review 2.  Sex Differences in Hypertension: Recent Advances.

Authors:  Ellen E Gillis; Jennifer C Sullivan
Journal:  Hypertension       Date:  2016-10-24       Impact factor: 10.190

3.  Left ventricular hypertrophy is a predictor of cardiovascular events in elderly hypertensive patients: Hypertension in the Very Elderly Trial.

Authors:  Riitta L Antikainen; Ruth Peters; Nigel S Beckett; Robert H Fagard; Ji-Guang Wang; Chakravarthi Rajkumar; Christopher J Bulpitt
Journal:  J Hypertens       Date:  2016-11       Impact factor: 4.844

Review 4.  Mechanistic Pathways of Sex Differences in Cardiovascular Disease.

Authors:  Vera Regitz-Zagrosek; Georgios Kararigas
Journal:  Physiol Rev       Date:  2017-01       Impact factor: 37.312

Review 5.  Prevalence of echocardiographic left-atrial enlargement in hypertension: a systematic review of recent clinical studies.

Authors:  Cesare Cuspidi; Marta Rescaldani; Carla Sala
Journal:  Am J Hypertens       Date:  2013-02-06       Impact factor: 2.689

6.  The rate of progression of renal disease may not be slower in women compared with men: a patient-level meta-analysis.

Authors:  Tazeen H Jafar; Christopher H Schmid; Paul C Stark; Robert Toto; Giuseppe Remuzzi; Piero Ruggenenti; Carmelita Marcantoni; Gavin Becker; Shahnaz Shahinfar; Paul E De Jong; Dick De Zeeuw; Anne-Lise Kamper; Svend Strangaard; Andrew S Levey
Journal:  Nephrol Dial Transplant       Date:  2003-10       Impact factor: 5.992

7.  Left atrial volume and geometry in healthy aging: the Cardiovascular Health Study.

Authors:  Gerard P Aurigemma; John S Gottdiener; Alice M Arnold; Marcello Chinali; Jeffrey C Hill; Dalane Kitzman
Journal:  Circ Cardiovasc Imaging       Date:  2009-05-11       Impact factor: 7.792

8.  Sex differences in hypertension-related renal and cardiovascular diseases in Italy: the I-DEMAND study.

Authors:  Maria Lorenza Muiesan; Ettore Ambrosioni; Francesco Vittorio Costa; Gastone Leonetti; Achille Cesare Pessina; Massimo Salvetti; Bruno Trimarco; Massimo Volpe; Roberto Pontremoli; Giacomo Deferrari; Enrico Agabiti Rosei
Journal:  J Hypertens       Date:  2012-12       Impact factor: 4.844

9.  Sex difference in cardiovascular risk: role of pulse pressure amplification.

Authors:  Véronique Regnault; Frédérique Thomas; Michel E Safar; Mary Osborne-Pellegrin; Raouf A Khalil; Bruno Pannier; Patrick Lacolley
Journal:  J Am Coll Cardiol       Date:  2012-05-15       Impact factor: 24.094

10.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

View more
  4 in total

Review 1.  The influence of sex on left ventricular remodeling in arterial hypertension.

Authors:  Marijana Tadic; Cesare Cuspidi; Guido Grassi
Journal:  Heart Fail Rev       Date:  2019-11       Impact factor: 4.214

Review 2.  Update on Management of Cardiovascular Diseases in Women.

Authors:  Fabiana Lucà; Maurizio Giuseppe Abrignani; Iris Parrini; Stefania Angela Di Fusco; Simona Giubilato; Carmelo Massimiliano Rao; Laura Piccioni; Laura Cipolletta; Bruno Passaretti; Francesco Giallauria; Angelo Leone; Giuseppina Maura Francese; Carmine Riccio; Sandro Gelsomino; Furio Colivicchi; Michele Massimo Gulizia
Journal:  J Clin Med       Date:  2022-02-22       Impact factor: 4.241

3.  The strain and strain rate imaging paradox in echocardiography: overabundant literature in the last two decades but still uncertain clinical utility in an individual case.

Authors:  Gian Luigi Nicolosi
Journal:  Arch Med Sci Atheroscler Dis       Date:  2020-12-26

4.  Angiotensin-converting enzyme inhibitors increase anti-fibrotic biomarkers in African Americans with left ventricular hypertrophy.

Authors:  Cesar A Romero; Shobi Mathew; Benjamin Wasinski; Brian Reed; Aaron Brody; Rachelle Dawood; Michael J Twiner; Candace D McNaughton; Rafael Fridman; John M Flack; Oscar A Carretero; Phillip D Levy
Journal:  J Clin Hypertens (Greenwich)       Date:  2021-03-10       Impact factor: 3.738

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.